Addressing Challenges in the Characterisation & Stability of AAV Vectors – A Biophysical Perspective
Time: 2:30 pm
day: Day One
Details:
- Examine the essential biophysical methods for evaluating AAV vectors in early clinical stages, focusing on determining full and empty particle ratios and selecting the appropriate techniques based on sample quality and development phase
- Discuss insights into choosing the right biophysical techniques based on specific sample conditions, highlighting the importance of monitoring
- Elaborate on regulatory aspects and how to implement new ICH Q2(R2) and Q14 guidelines
